Return to search

Oral anticoagulants for stroke prevention in nonvalvular AF

Yes / Warfarin and direct oral anticoagulants (DOACs) have been shown to reduce the risk of stroke in patients with atrial fibrillation, yet many patients are still not being anticoagulated. This article discusses the barriers to the initiation of oral anticoagulants, in particular DOACs, and how these can be overcome.

Identiferoai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/16145
Date January 2017
CreatorsMedlinskiene, Kristina, Petty, Duncan R.
Source SetsBradford Scholars
LanguageEnglish
Detected LanguageEnglish
TypeArticle, Accepted manuscript
Rights© 2018 Wiley. This is the accepted manuscript version of the article above which has been published in final form at https://doi.org/10.1002/psb.1611. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving., Unspecified

Page generated in 0.0021 seconds